EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database

Gyubi Lee, Seung Hyeon Lee, Ju-Young Shin, Hyesung Lee

Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 96-107

DOI: 10.56142/perm.26.0007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Gyubi Lee und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lee, G., Lee, S. H., Shin, J., & Lee, H. (2026). Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database. Journal of Pharmacoepidemiology and Risk Management, 18(1), 96-107. https://doi.org/10.56142/perm.26.0007

Vancouver

Lee G, Lee SH, Shin J, Lee H. Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):96-107. doi:10.56142/perm.26.0007

BibTeX
@article{Lee2026,
  author = {Lee, Gyubi and Lee, Seung Hyeon and Shin, Ju-Young and Lee, Hyesung},
  title = {Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database},
  journal = {Journal of Pharmacoepidemiology and Risk Management},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {96--107},
  doi = {10.56142/perm.26.0007}
}
Kostenlos starten →